{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444424244
| IUPAC_name = 3-hydroxy-1-isopropylindoline-5,6-dione 5-semicarbazone
| image = Iprazochrome.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|iprazochrome}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 7248-21-7
| ATC_prefix = N02
| ATC_suffix = CX03
| PubChem = 6381821
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2104324	
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 903A9K181P
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07297
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 4903581

<!--Chemical data-->
| chemical_formula =  
| C=12 | H=16 | N=4 | O=3 
| molecular_weight = 264.28 g/mol
| smiles            = CC(C)N1CC(C2=C/C(=N/NC(=O)N)/C(=O)C=C21)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C12H16N4O3/c1-6(2)16-5-11(18)7-3-8(14-15-12(13)19)10(17)4-9(7)16/h3-4,6,11,18H,5H2,1-2H3,(H3,13,15,19)/b14-8-
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = XZKVIDLLLOUTSS-ZSOIEALJSA-N
| synonyms = <small>[(3-hydroxy-1-isopropyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea</small>
}}

'''Iprazochrome''' is an [[antimigraine]] agent. It is a [[serotonin antagonist]].<ref name="pmid2639158">{{cite journal |author=Hampf G |title=Effect of serotonin antagonists on patients with atypical facial pain |journal=J Craniomandib Disord |volume=3 |issue=4 |pages=211â€“2 |year=1989 |pmid=2639158 |doi= |url=}}</ref>

==References==
{{Reflist}}


{{Antimigraine preparations}}
{{Serotonergics}}

[[Category:Antimigraine drugs]]
[[Category:Semicarbazones]]
[[Category:Indolines]]
[[Category:Alcohols]]


{{analgesic-stub}}